Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Exchange Rate Effect: 2015-2025

Historic Exchange Rate Effect for Sunshine Biopharma (SBFM) over the last 10 years, with Sep 2025 value amounting to -$228,322.

  • Sunshine Biopharma's Exchange Rate Effect fell 129.56% to -$228,322 in Q3 2025 from the same period last year, while for Sep 2025 it was -$538,133, marking a year-over-year decrease of 695.90%. This contributed to the annual value of -$1.0 million for FY2024, which is 295.28% down from last year.
  • According to the latest figures from Q3 2025, Sunshine Biopharma's Exchange Rate Effect is -$228,322, which was down 168.02% from $335,684 recorded in Q2 2025.
  • Sunshine Biopharma's Exchange Rate Effect's 5-year high stood at $772,282 during Q3 2024, with a 5-year trough of -$636,577 in Q2 2024.
  • Moreover, its 3-year median value for Exchange Rate Effect was -$10,197 (2025), whereas its average is -$37,443.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first spiked by 5,230.70% in 2022, then tumbled by 21,944.31% in 2024.
  • Over the past 5 years, Sunshine Biopharma's Exchange Rate Effect (Quarterly) stood at -$5,664 in 2021, then spiked by 5,230.70% to $290,603 in 2022, then skyrocketed by 71.47% to $498,306 in 2023, then slumped by 227.49% to -$635,298 in 2024, then slumped by 129.56% to -$228,322 in 2025.
  • Its Exchange Rate Effect stands at -$228,322 for Q3 2025, versus $335,684 for Q2 2025 and -$10,197 for Q1 2025.